Robert G. Shawah, Dipexium Pharmaceuticals, Inc.'s Chief Accounting Officer, just received 35,000 options from the company. The strike price of the options received was $11.35, and these expire on January 05, 2025. Shawah now owns at least 120 options on the company.
Some additional info was provided as follows:
Options vest as follows: 50% on the date of grant and the remaining 50% vests in equal installments over a 24 month period, subject to accelerated vesting on a change of control.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Dipexium Pharmaceuticals, Inc. Just Filed Its Quarterly Report: Loss per share Basic... - Nov. 9, 2017
Departure of Directors or Certain - Oct. 27, 2017